|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Singletary SE: Rating the risk factors for
breast cancer. Ann Surg. 237:474–482. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berman AT, Thukral AD, Hwang WT, Solin LJ
and Vapiwala N: Incidence and patterns of distant metastases for
patients with early-stage breast cancer after breast conservation
treatment. Clin Breast Cancer. 13:88–94. 2013. View Article : Google Scholar
|
|
4
|
Giordano SH, Cohen DS, Buzdar AU, Perkins
G and Hortobagyi GN: Breast carcinoma in men: a population-based
study. Cancer. 101:51–57. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prat A and Perou CM: Deconstructing the
molecular portraits of breast cancer. Mol Oncol. 5:5–23. 2011.
View Article : Google Scholar
|
|
6
|
Nilsson S, Koehler KF and Gustafsson JA:
Development of subtype-selective oestrogen receptor-based
therapeutics. Nat Rev Drug Discov. 10:778–792. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Higgins MJ and Baselga J: Targeted
therapies for breast cancer. J Clin Invest. 121:3797–3803. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim TH, Shin YJ, Won AJ, Lee BM, Choi WS,
Jung JH, Chung HY and Kim HS: Resveratrol enhances chemosensitivity
of doxorubicin in multidrug-resistant human breast cancer cells via
increased cellular influx of doxorubicin. Biochim Biophys Acta.
1840:615–625. 2014. View Article : Google Scholar
|
|
10
|
Ullah MF: Cancer multidrug resistance
(MDR): a major impediment to effective chemotherapy. Asian Pac J
Cancer Prev. 9:1–6. 2008.PubMed/NCBI
|
|
11
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sharom FJ: ABC multidrug transporters:
structure, function and role in chemoresistance. Pharmacogenomics.
9:105–127. 2008. View Article : Google Scholar
|
|
13
|
Choudhuri S and Klaassen CD: Structure,
function, expression, genomic organization, and single nucleotide
polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP)
efflux transporters. Int J Toxicol. 25:231–259. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pressman BC: Antibiotic models for
carrier-mediated transport through membranes. Antimicrob. Agents
Chemother (Bethesda). 9:28–34. 1969.
|
|
15
|
Rutkowski J and Brzezinski B: Structures
and properties of naturally occurring polyether antibiotics. Biomed
Res Int. 2013:1–31. 2013. View Article : Google Scholar
|
|
16
|
Naujokat C, Fuchs D and Opelz G:
Salinomycin in cancer: A new mission for an old agent. Mol Med Rep.
3:555–559. 2010. View Article : Google Scholar
|
|
17
|
Gupta PB, Onder TT, Jiang G, Tao K,
Kuperwasser C, Weinberg RA and Lander ES: Identification of
selective inhibitors of cancer stem cells by high-throughput
screening. Cell. 138:645–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Al Dhaheri Y, Attoub S, Arafat K, Abuqamar
S, Eid A, Al Faresi N and Iratni R: Salinomycin induces apoptosis
and senescence in breast cancer: upregulation of p21,
downregulation of survivin and histone H3 and H4 hyperacetylation.
Biochim Biophys Acta. 1830:3121–3135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim KY, Yu SN, Lee SY, Chun SS, Choi YL,
Park YM, Song CS, Chatterjee B and Ahn SC: Salinomycin-induced
apoptosis of human prostate cancer cells due to accumulated
reactive oxygen species and mitochondrial membrane depolarization.
Biochem Biophys Res Commun. 413:80–86. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fuchs D, Daniel V, Sadeghi M, Opelz G and
Naujokat C: Salinomycin overcomes ABC transporter-mediated
multidrug and apoptosis resistance in human leukemia stem cell-like
KG-1a cells. Biochem Biophys Res Commun. 394:1098–1104. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Verdoodt B, Vogt M, Schmitz I, Liffers ST,
Tannapfel A and Mirmohammadsadegh A: Salinomycin induces autophagy
in colon and breast cancer cells with concomitant generation of
reactive oxygen species. PLoS One. 7:e441322012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoon MJ, Kang YJ, Kim IY, Kim EH, Lee JA,
Lim JH, Kwon TK and Choi KS: Monensin, a polyether ionophore
antibiotic, overcomes TRAIL resistance in glioma cells via
endoplasmic reticulum stress, DR5 upregulation and c-FLIP
downregulation. Carcinogenesis. 34:1918–1928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu CP, Calcagno AM and Ambudkar SV:
Reversal of ABC drug transporter-mediated multidrug resistance in
cancer cells: evaluation of current strategies. Curr Mol Pharmacol.
1:93–105. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thomas H and Coley HM: Overcoming
multidrug resistance in cancer: an update on the clinical strategy
of inhibiting p-glycoprotein. Cancer Control. 10:159–165.
2003.PubMed/NCBI
|
|
25
|
Rahman AM, Yusuf SW and Ewer MS:
Anthracycline-induced cardiotoxicity and the cardiac-sparing effect
of liposomal formulation. Int J Nanomedicine. 2:567–583. 2007.
|
|
26
|
Liu Y, Liu H, Han B and Zhang JT:
Identification of 14-3-3sigma as a contributor to drug resistance
in human breast cancer cells using functional proteomic analysis.
Cancer Res. 66:3248–3255. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vulsteke C, Lambrechts D, Dieudonné A, et
al: Genetic variability in the multidrug resistance associated
protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast
cancer patients receiving (neo-) adjuvant chemotherapy with
5-fluorouracil, epirubicin and cyclophosphamide (FEC). Ann Oncol.
24:1513–1525. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Riccioni R, Dupuis ML, Bernabei M,
Petrucci E, Pasquini L, Mariani G, Cianfriglia M and Testa U: The
cancer stem cell selective inhibitor salinomycin is a
p-glycoprotein inhibitor. Blood Cells Mol Dis. 45:86–92. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Le Guennec JY, Ouadid-Ahidouch H, Soriani
O, Besson P, Ahidouch A and Vandier C: Voltage-gated ion channels,
new targets in anti-cancer research. Recent Pat Anticancer Drug
Discov. 2:189–202. 2007. View Article : Google Scholar
|
|
30
|
Tsubaki M, Komai M, Itoh T, Imano M,
Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D,
Mukai J, Sakaguchi K, Satou T and Nishida S: By inhibiting Src,
verapamil and dasatinib overcome multidrug resistance via increased
expression of Bim and decreased expressions of MDR1 and survivin in
human multidrug-resistant myeloma cells. Leuk Res. 38:121–130.
2014. View Article : Google Scholar
|
|
31
|
De Souza PS, da Cunha Vasconcelos F, Silva
LF and Maia RC: Cyclosporine A enables vincristine-induced
apoptosis during reversal of multidrug resistance phenotype in
chronic myeloid leukemia cells. Tumour Biol. 33:943–956. 2012.
View Article : Google Scholar : PubMed/NCBI
|
